Literature DB >> 19469031

IDH1 and IDH2 mutations in gliomas.

François Ducray, Yannick Marie, Marc Sanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19469031

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  27 in total

1.  MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status.

Authors:  K Yamashita; A Hiwatashi; O Togao; K Kikuchi; R Hatae; K Yoshimoto; M Mizoguchi; S O Suzuki; T Yoshiura; H Honda
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-24       Impact factor: 3.825

2.  Prevalence and Prognostic Value of IDH1 R132 Mutation in Newly Diagnosed AML Egyptian Patients with Normal Karyotype.

Authors:  Dalia Salem; Sherin Abd El-Aziz; Nadia El-Menshawy; Tarek Abouzeid; Mohamed Ebrahim
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-18       Impact factor: 0.900

3.  Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.

Authors:  Whitney B Pope; Robert M Prins; M Albert Thomas; Rajakumar Nagarajan; Katharine E Yen; Mark A Bittinger; Noriko Salamon; Arthur P Chou; William H Yong; Horacio Soto; Neil Wilson; Edward Driggers; Hyun G Jang; Shinsan M Su; David P Schenkein; Albert Lai; Timothy F Cloughesy; Harley I Kornblum; Hong Wu; Valeria R Fantin; Linda M Liau
Journal:  J Neurooncol       Date:  2011-10-21       Impact factor: 4.130

4.  Lentiviral-induced high-grade gliomas in rats: the effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H.

Authors:  John Lynes; Mia Wibowo; Carl Koschmann; Gregory J Baker; Vandana Saxena; A K M G Muhammad; Niyati Bondale; Julia Klein; Hikmat Assi; Andrew P Lieberman; Maria G Castro; Pedro R Lowenstein
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 5.  Insights into molecular therapy of glioma: current challenges and next generation blueprint.

Authors:  Y Rajesh; Ipsita Pal; Payel Banik; Sandipan Chakraborty; Sachin A Borkar; Goutam Dey; Ahona Mukherjee; Mahitosh Mandal
Journal:  Acta Pharmacol Sin       Date:  2017-03-20       Impact factor: 6.150

6.  Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.

Authors:  Roh-Eul Yoo; Tae Jin Yun; Inpyeong Hwang; Eun Kyoung Hong; Koung Mi Kang; Seung Hong Choi; Chul-Kee Park; Jae-Kyung Won; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2019-08-29       Impact factor: 5.315

Review 7.  O-GlcNAc signaling in cancer metabolism and epigenetics.

Authors:  Jay Prakash Singh; Kaisi Zhang; Jing Wu; Xiaoyong Yang
Journal:  Cancer Lett       Date:  2014-04-24       Impact factor: 8.679

Review 8.  Molecular characteristics of pediatric high-grade gliomas.

Authors:  Omar Chamdine; Amar Gajjar
Journal:  CNS Oncol       Date:  2014-11

9.  Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.

Authors:  Stefan Gross; Rob A Cairns; Mark D Minden; Edward M Driggers; Mark A Bittinger; Hyun Gyung Jang; Masato Sasaki; Shengfang Jin; David P Schenkein; Shinsan M Su; Lenny Dang; Valeria R Fantin; Tak W Mak
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 17.579

10.  Identifying the genes regulated by IDH1 via gene-chip in glioma cell U87.

Authors:  Jie Ren; Meiqing Lou; Jinlong Shi; Yajun Xue; Daming Cui
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.